Community Research and Development Information Service - CORDIS

H2020

PRO-CF-MED

Project reference: 633545
Funded under

Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication

From 2015-05-01 to 2017-12-31, ongoing project

Project details

Total cost:

EUR 21 237 179,5

EU contribution:

EUR 5 997 139

Coordinated in:

Netherlands

Call for proposal:

H2020-PHC-2014-two-stageSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Related information

Coordinator

PROQR THERAPEUTICS NV
Netherlands

EU contribution: EUR 4 442 544


ZERNIKEDREEF 9
2333 CK LEIDEN
Netherlands

Participants

EUROPEAN CYSTIC FIBROSIS SOCIETY
Denmark

EU contribution: EUR 256 260


KASTANIEPARKEN 7
7470 KARUP
Denmark
UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

EU contribution: EUR 369 072,5


PLACE DE L UNIVERSITE 1
1348 LOUVAIN LA NEUVE
Belgium
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 359 927,5


RUE DE TOLBIAC 101
75654 PARIS
France
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

EU contribution: EUR 338 250


HEIDELBERGLAAN 100
3584 CX UTRECHT
Netherlands
PATERGRUS BVBA
Belgium

EU contribution: EUR 231 085


SPARHOEKDREEF 57
9880 AALTER
Belgium
Record Number: 193242 / Last updated on: 2016-08-23